Tafasitamab

Category: Cancer



Tafasitamab Overview

Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).[1] Tafasitamab is a humanized Fc-modified cytolytic CD19 antibody.[1][2] Tafasitamab was approved for medical use in the United States in July 2020.[3][2] Contents 1 Medical uses 2 Society and culture 2.1 Names 3 Re...

Read more Tafasitamab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tafasitamab

Recent Tafasitamab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tafasitamab
  • Injection: 12mg/kg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tafasitamab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA